📰 Squarepoint Ops News
Page 147 - Squarepoint Ops News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Squarepoint Ops. Real-time updates on events, politics, business and more.
April 2, 2023
StockNews.com started coverage on shares of Xperi (NASDAQ:XPER – Get Rating) in a research note released on Wednesday. The brokerage issued a strong-buy rating on the semiconductor company’s stock. Other research analysts have also recently issued reports about the stock. Maxim Group decreased their price objective on shares of Xperi from $23.00 to $19.00 and […]
April 2, 2023
Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Rating) have been assigned an average recommendation of “Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the […]
April 2, 2023
Immunocore Holdings plc (NASDAQ:IMCR – Get Rating) was the recipient of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 2,300,000 shares, an increase of 10.0% from the February 28th total of 2,090,000 shares. Approximately 4.9% of the shares of the company are sold […]
April 2, 2023
StockNews.com upgraded shares of Luxfer (NYSE:LXFR – Get Rating) from a hold rating to a buy rating in a research report sent to investors on Wednesday morning. Other equities analysts have also recently issued research reports about the stock. TheStreet raised shares of Luxfer from a c+ rating to a b- rating in a research […]
April 2, 2023
Arcutis Biotherapeutics (NASDAQ:ARQT – Get Rating) had its price objective trimmed by Truist Financial from $50.00 to $45.00 in a research note issued to investors on Wednesday, The Fly reports. The firm currently has a buy rating on the stock. Several other research firms have also issued reports on ARQT. Morgan Stanley dropped their price […]
April 2, 2023
Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE – Get Rating) saw a significant growth in short interest in the month of March. As of March 15th, there was short interest totalling 134,150,000 shares, a growth of 16.1% from the February 28th total of 115,590,000 shares. Based on an average trading volume of 53,060,000 shares, the short-interest […]
April 1, 2023
Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Get Rating) CAO William T. Roberts sold 912 shares of the stock in a transaction that occurred on Wednesday, March 29th. The stock was sold at an average price of $17.50, for a total value of $15,960.00. Following the completion of the sale, the chief accounting officer now directly owns […]
April 1, 2023
Highwoods Properties, Inc. (NYSE:HIW – Get Rating) was the target of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 2,640,000 shares, an increase of 13.8% from the February 28th total of 2,320,000 shares. Based on an average daily volume of 964,200 shares, the […]
April 1, 2023
Vicarious Surgical Inc (NYSE:RBOT – Get Rating) Director Philip Liang purchased 73,900 shares of the business’s stock in a transaction on Monday, March 27th. The stock was acquired at an average price of $2.07 per share, with a total value of $152,973.00. Following the purchase, the director now directly owns 623,105 shares in the company, […]
April 1, 2023
The RealReal, Inc. (NASDAQ:REAL – Get Rating) was the recipient of a significant drop in short interest during the month of March. As of March 15th, there was short interest totalling 12,680,000 shares, a drop of 17.7% from the February 28th total of 15,410,000 shares. Approximately 16.0% of the company’s shares are sold short. Based […]